BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38273320)

  • 1. CircRAD23B promotes proliferation and carboplatin resistance in ovarian cancer cell lines and organoids.
    Wang H; Zhang Y; Miao H; Xu T; Nie X; Cheng W
    Cancer Cell Int; 2024 Jan; 24(1):42. PubMed ID: 38273320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of circRAD23B Exerts Antitumor Response in Colorectal Cancer via the Regulation of miR-1205/TRIM44 axis.
    Han B; Wang X; Yin X
    Dig Dis Sci; 2022 Feb; 67(2):504-515. PubMed ID: 33634427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA Circ_0025033 Promotes the Evolvement of Ovarian Cancer Through the Regulation of miR-330-5p/KLK4 Axis.
    Cheng H; Wang N; Tian J; Li Y; Ren L; Shi Z
    Cancer Manag Res; 2020; 12():2753-2765. PubMed ID: 32425594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GATA1-induced upregulation of LINC01503 promotes carboplatin resistance in ovarian carcinoma by upregulating PD-L1 via sponging miR-766-5p.
    Li Y; Zhai Y; Chen Y
    J Ovarian Res; 2021 Aug; 14(1):108. PubMed ID: 34425872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circ_0015756 promotes the progression of ovarian cancer by regulating miR-942-5p/CUL4B pathway.
    Du Z; Wang L; Xia Y
    Cancer Cell Int; 2020 Nov; 20(1):572. PubMed ID: 33292255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circ_0007841 knockdown confers cisplatin sensitivity to ovarian cancer cells by down-regulation of NFIB expression in a miR-532-5p-dependent manner.
    Gao Y; Huang Y
    J Chemother; 2023 Apr; 35(2):117-130. PubMed ID: 35380509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CircRAD23B facilitates proliferation and invasion of esophageal cancer cells by sponging miR-5095.
    Lan X; Liu X; Sun J; Yuan Q; Li J
    Biochem Biophys Res Commun; 2019 Aug; 516(2):357-364. PubMed ID: 31208717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA XIST promotes carboplatin resistance of ovarian cancer through activating autophagy via targeting miR-506-3p/FOXP1 axis.
    Xia X; Li Z; Li Y; Ye F; Zhou X
    J Gynecol Oncol; 2022 Nov; 33(6):e81. PubMed ID: 36335987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circ_0078607 inhibits the progression of ovarian cancer via regulating the miR-32-5p/SIK1 network.
    Jin Y; Wang H
    J Ovarian Res; 2022 Jan; 15(1):3. PubMed ID: 34983607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of circRNA_100290 promotes the progression of laryngeal squamous cell carcinoma through the miR-136-5p/RAP2C axis.
    Wang Z; Huang C; Zhang A; Lu C; Liu L
    Biomed Pharmacother; 2020 May; 125():109874. PubMed ID: 32014687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of circ-PIP5K1A overcomes resistance to cisplatin in ovarian cancer by miR-942-5p/NFIB axis.
    Sheng H; Wang X
    Anticancer Drugs; 2023 Feb; 34(2):214-226. PubMed ID: 36730637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA WDFY3-AS2 promotes cisplatin resistance and the cancer stem cell in ovarian cancer by regulating hsa-miR-139-5p/SDC4 axis.
    Wu Y; Wang T; Xia L; Zhang M
    Cancer Cell Int; 2021 May; 21(1):284. PubMed ID: 34051810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LEMD1-AS1 Suppresses Ovarian Cancer Progression Through Regulating miR-183-5p/TP53 Axis.
    Guo R; Qin Y
    Onco Targets Ther; 2020; 13():7387-7398. PubMed ID: 32801762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma.
    Cheng J; Zhang R; Yan M; Li Y
    BMC Cancer; 2022 Mar; 22(1):238. PubMed ID: 35241028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. F-Box and Leucine-Rich Repeat Protein 20 (FBXL20), Negatively Regulated by microRNA (miR)-195-5p, Accelerates the Malignant Progression of Ovarian Cancer.
    Wu D; Liu C; Hong L
    Mol Biotechnol; 2021 Dec; 63(12):1235-1243. PubMed ID: 34338995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
    Hao T; Huang S; Han F
    Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circ_0026123 promotes cisplatin resistance and progression of ovarian cancer by upregulating RAB1A through sequestering miR-543.
    Wei L; He W; Zhao H; Zhao P
    Anticancer Drugs; 2022 Nov; 33(10):1069-1080. PubMed ID: 36255068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ_0078607 increases platinum drug sensitivity via miR-196b-5p/GAS7 axis in ovarian cancer.
    Dai C; Dai SY; Gao Y; Yan T; Zhou QY; Liu SJ; Liu X; Deng DN; Wang DH; Qin QF; Zi D
    Epigenetics; 2023 Dec; 18(1):2175565. PubMed ID: 36908025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of hsa_circRNA_102958 Indicates Poor Prognosis and Promotes Ovarian Cancer Progression Through miR-1205/SH2D3A Axis.
    Wang G; Zhang H; Li P
    Cancer Manag Res; 2020; 12():4045-4053. PubMed ID: 32547237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis.
    Xie H; Yao J; Wang Y; Ni B
    Drug Deliv; 2022 Dec; 29(1):1257-1271. PubMed ID: 35467477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.